Allogeneic bone marrow transplantation for chronic myeloid leukemia: a retrospective study of busulfan-cytoxan versus total body irradiation-cytoxan as preparative regimen in Koreans

Clinical Transplantation
I KimC C Kim

Abstract

From January 1990 to December 1997, 53 Korean patients with chronic myeloid leukemia (CML) receiving bone marrow transplantation (BMT) from human leucocyte antigen (HLA)-identical sibling donors conditioned with either busulfan and cyclophosphamide (BU/CY regimen) or total body irradiation and cyclophosphamide (TBI/CY regimen) were compared retrospectively. Transplantation-related mortality was 19% in BU/CY and 12% in TBI/CY, and early death (<100 d) occurred in 3 patients conditioned with BU/CY. Grade II-IV acute graft-versus-host disease (GVHD) was 9% of BU/CY and 52% of TBI/CY patients. Overall incidence of chronic GVHD was 50% of BU/CY and 52% of TBI/CY patients. In patients with chronic phase, 5-yr overall survival was 73% in the BU/CY group compared with 87% in the TBI/CY group (p=NS), and overall disease-free survival was 75% in the BU/CY group and 59% in the TBI/CY group (p=NS). So far, with a median follow-up of 45 months, 11 patients have relapsed; three relapses occurred after BU/CY and 8 after TBI/CY. The actuarial 5-yr relapse rate was 15% after BU/CY, 34% after TBI/CY (p=0.46). For patients transplanted in chronic phase within 1 yr after diagnosis, there was a clear trend for a lower relapse rate in the BU/CY grou...Continue Reading

References

Apr 24, 1975·The New England Journal of Medicine·E D ThomasC D Buckner
Jan 1, 1986·International Journal of Cell Cloning·K M Sullivan
Mar 1, 1995·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·H KitaH Chigasaki

Citations

Nov 15, 2002·International Journal of Hematology·John M BennettStephen J Forman
Oct 17, 2003·Hematology/oncology Clinics of North America·Alan S Wayne, A J Barrett
Nov 3, 2010·International Journal of Radiation Oncology, Biology, Physics·Mete YeginerBulent Aydogan
Jul 21, 2009·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·T ZilliM Ozsahin
May 10, 2011·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Wei TangJiong Hu
Nov 5, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Theresa HahnOlle Ringdén
May 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·T L KissH A Messner
Jun 23, 2006·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Amr A El-HusseiniMohamed A Ghoneim

Related Concepts

n-Butane-1,3-di(methylsulfonate)
Cyclophosphamide, (S)-Isomer
Drug Administration Schedule
Graft-vs-Host Disease
Immunosuppressive Agents
Relapse
Retrospective Studies
Whole-Body Irradiation
Myeloid Leukemia, Chronic
Bone Marrow Cell Transplantation

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.